Insiders · ADMP

Ebrahim Versi

Officer, Director at DMK PHARMACEUTICALS Corp (ADMP) since May 2023

Ebrahim Versi has filed 3 insider reports with the SEC since May 2023, as officer and director at DMK PHARMACEUTICALS Corp (ADMP). The latest filing, on September 19, 2023, reports conversion of a derivative at DMK PHARMACEUTICALS Corp (ADMP).

Filings
3
Companies
1
Bought on market
None
Sold on market
None

Companies where Ebrahim Versi is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
DMK PHARMACEUTICALS Corp logo
ADMP
DMK PHARMACEUTICALS Corp
Officer, Directorsince May 20238,745Sep 19, 2023

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Ebrahim Versi with

Questions about Ebrahim Versi

What is Ebrahim Versi's role at DMK PHARMACEUTICALS Corp?
Ebrahim Versi reports to the SEC as officer and director at DMK PHARMACEUTICALS Corp (ADMP), according to the latest filing on September 19, 2023.
How many shares does Ebrahim Versi own?
After the latest filing that states it, Ebrahim Versi directly owned 8,745 shares of DMK PHARMACEUTICALS Corp (ADMP). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Ebrahim Versi bought or sold stock recently?
No open-market purchases or sales by Ebrahim Versi are on file. The filings report conversion of a derivative and grant or award.
How do I get alerts when Ebrahim Versi files?
Follow Ebrahim Versi on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Ebrahim Versi (SEC CIK 0001978256). Totals count each trade once, skipping amendments whose original is on file, from May 30, 2023 on. View on SEC EDGAR